Clinical Trials Browser

INDUSTRY × Has announcements × infigratinib × Clear all

NCT02150967 2023-07-03

A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma

Phase 2 Terminated

143 enrolled 25 charts 1 FDA

Gastrointestinal

Cholangiocarcinoma